SVRA compared with TRVI: revenue, margins and what each company keeps, and the suppliers and customers both name

SVRASavara Inc

Mkt capRevenueRevenue

TRVITrevi Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SVRASavara Inc

TRVITrevi Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SVRA: latest quarter not drawable. TRVI: latest quarter not drawable.Method ›

Price

rebased to 0%

SVRA, solidTRVI, dashed

SVRASavara Inc

4.72▼−2.05%· post 4.72

Mkt cap$990.3M

TRVITrevi Therapeutics, Inc.

13.63▲+0.52%· post 13.63

ClosedNov 2 '26

Mkt cap$1.9B

Compare

ClosedNov 2 '26

SVRASavara Inc

TRVITrevi Therapeutics, Inc.

4.72▼−2.05%post 4.72

Price

13.63▲+0.52%post 13.63

$990.3M

Mkt cap

$1.9B

SVRA4.72▼−2.05%vsTRVI13.63▲+0.52%ClosedNov 2 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SVRA 7

—FUJIFILM Diosynth Biotechnologiesunlistedsupplier

—GEMA Biotechunlistedsupplier

—Parexelunlistedsupplier

—PARI Pharma GmbHunlistedsupplier

3 more · SVRA chain ›

Shared 0

No shared counterparties.

Only TRVI 2

—Keenova Therapeuticsunlistedsupplier

—Par Healthunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR